re: is there enough cash in vcr? This company has a long road to hoe on the path to commercialisation. The simple funding of tests is a far cry from the economic realities of manufacture, marketing and distribution.
It stands to reason that no one would give a ghost of a chance to surviving by trial funding. The US companies have already found it a nightmare to get paid for implants under their health schemes.
There is a lot more golf left in this game of trying to get this idea to market. The destination therapy market looks doubtful and the operation is too gruelling and excruciating for the short term destination therapy.
I'll be looking forward to seeing my short positions rewarded. Get advice before you invest. This is just a humble opinion.
VCR
ventracor limited
